Core Viewpoint - Colgate's recent promotional claims about its toothpaste's ability to naturally close gaps between teeth have sparked significant controversy, raising questions about the company's adherence to scientific standards and consumer trust [2][3]. Group 1: Company Actions - Colgate's livestream account has been accused of misleading advertising by suggesting that its toothpaste can repair dental gaps, a claim that contradicts established scientific understanding [2]. - Despite public backlash and a statement from a content creator whose video was misused, Colgate's livestream continued to promote these claims without any apparent corrective action [2]. Group 2: Industry Implications - The incident highlights the risks associated with false advertising in the consumer goods sector, particularly for established brands like Colgate, which could damage their reputation and consumer trust [3]. - Other brands are cautioned to maintain integrity in their marketing practices, as misleading claims can lead to consumer backlash and loss of market share [3].

Group 1 - Colgate is accused of unauthorized use of content from a self-media blogger, which includes editing and altering original video material for commercial promotion [2][3] - The blogger claims that Colgate's actions mislead consumers by suggesting the toothpaste can "close gaps" and "repair teeth," which are not mentioned in the original content [3] - The blogger demands that Colgate cease the distribution of the infringing content and communicate regarding the infringement and responsibility [3] Group 2 - Colgate's customer service has stated they are unaware of the situation and have not provided a response to inquiries from the media [5] - The product in question has sold over 180,000 units, promoting effects such as "sensitivity repair," but has faced consumer complaints regarding exaggerated claims and lack of effectiveness [5] - Regulatory bodies are increasing scrutiny on toothpaste advertising practices, with new regulations set to take effect on December 1, 2023, requiring manufacturers to ensure compliance with safety and efficacy claims [8][9]